3-(3-Chlorophenyl)-3-oxopropanenitrile → 4-chloro-3-(3-chlorophenyl)-1-methyl-5-phenyl-1H-pyrazolo[3,4-c]pyridazine

HRID 1525384

반응식

HRID 1525384 반응식
[Cl:1][C:2]1[C:7]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)=[N:6][N:5]=[C:4]2[N:14]([CH3:24])[N:15]=[C:16](C3C=CC=CC=3Cl)[C:3]=12.[Cl:25][C:26]1[CH:27]=[C:28]([CH:34]=[CH:35][CH:36]=1)C(CC#N)=O>>[Cl:1][C:2]1[C:7]([C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=2)=[N:6][N:5]=[C:4]2[N:14]([CH3:24])[N:15]=[C:16]([C:35]3[CH:34]=[CH:28][CH:27]=[C:26]([Cl:25])[CH:36]=3)[C:3]=12

참가 물질

3

실험 절차

Compound 13 was synthesised following similar procedures outlined in Example 1 (Compound 37), using 3-chlorobenzoylacetonitrile instead of 2-chlorobenzoyl acetonitrile in Step 1.

출처 및 근거

ORD 기록
ord-522bb3bacccf40b583190480439345f6
출처 데이터셋
uspto-grants-2015_07
특허 번호
US09079909B2

연결된 노트

불러오는 중…